Blood pressure lowering effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA)

Hypertens Res. 2024 Mar;47(3):803-804. doi: 10.1038/s41440-023-01569-4. Epub 2024 Jan 5.
No abstract available

Keywords: Blood pressure; Glucagon-like peptide-1 receptor agonists; Sodium-glucose cotransporter 2 inhibitors; Type 2 diabetes.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Blood Pressure
  • Diabetes Mellitus, Type 2* / drug therapy
  • Glucagon-Like Peptide-1 Receptor Agonists*
  • Glucose
  • Glucosides*
  • Humans
  • Sodium
  • Thiophenes*

Substances

  • ipragliflozin
  • Glucagon-Like Peptide-1 Receptor Agonists
  • Glucose
  • Sodium
  • Glucosides
  • Thiophenes